Mercer Global Advisors 13F: Adds $1.9M to A Stake

Mercer Global Advisors Boosts Agilent Technologies Position

Mercer Global Advisors increased its holdings in Agilent Technologies, Inc. (NYSE: A) during the quarter, according to a Form 13F filing with the U.S. Securities and Exchange Commission. The firm lifted its position by 23.4%, buying an additional 14,192 shares. That brought its total holdings to 74,734 shares.

Value of the Agilent Technologies Holding

The added shares pushed the total value of Mercer Global Advisors' investment in Agilent Technologies to approximately $9.85 million as of the reporting date. Because 13F filings are backward-looking documents that reflect holdings at the close of a specific quarter, they may not capture the firm's current position. Even so, the purchase shows the firm expanded its exposure to the healthcare diagnostics provider.

Agilent Technologies Stock and Valuation Context

Agilent Technologies shares change hands on the New York Stock Exchange. The stock trades close to its 200-day moving average of $131.61, sitting near the spot price of $131.84. The company carries a price-to-earnings ratio of 31.94 alongside a forward price-to-earnings ratio of 23.97.

Dividend and Payout Details

Agilent Technologies returns capital to shareholders through an annual dividend rate of $1.02 per share, which translates to a dividend yield of 0.65%. The company maintains a conservative dividend payout ratio of 19.98%, leaving plenty of earnings to reinvest back into its diagnostics and life sciences operations.

Wall Street Analyst Actions and Price Targets

Financial institutions have adjusted their outlooks for Agilent Technologies in recent months. On October 13, 2026, TD Cowen kept its buy rating while raising its price target from $180.00 to $196.00. Morgan Stanley kept an overweight rating on the same day, lifting its target from $175.00 to $190.00. Barclays also kept an overweight rating on October 7, 2026, boosting its target to $195.00 from $175.00. Earlier in August, Wells Fargo maintained an overweight rating with a target of $180.00, while Stifel, B of A Securities, Citigroup, and Goldman Sachs reiterated buy ratings with various target increases. Overall, analysts hold a consensus buy recommendation on the stock with a mean price target of $175.43.

Inside Agilent Technologies Operations

Headquartered in Santa Clara, California, Agilent Technologies provides application-focused laboratory instruments, software, and consumables to the life sciences, diagnostics, and applied chemical sectors. The company operates through three key divisions focusing on life sciences markets, cross-lab services, and applied markets. This filing follows earlier reported institutional moves earlier in the year, including a massive new position by Vanguard and sizable stake adjustments by other major asset managers.

What to Watch Next for Agilent Technologies

Investors tracking Agilent Technologies will want to monitor upcoming SEC filings to see if Mercer Global Advisors and other institutional investors continue building their stakes. The company's next financial results are scheduled for release on November 25, 2026, which will provide fresh data on revenue growth, earnings per share, and overall segment performance.